Participants 49 89 3
antihistaminic (H1) effect of bilastine.
Participants 166 284 7
bilastine, a new histamine H(1) receptor antagonist, from single- and multiple-dose studies in healthy adult subjects.
Participants 387 522 7
In the single-dose studies, a total of 183 subjects received oral doses of bilastine 2.5, 5, 10, 20, 50, 100, 120, 160, 200 and 220 mg.
Participants 523 687 7
In the multiple-dose studies, 127 healthy subjects received bilastine 10, 20, 40, 50, 80, 100, 140 or 200 mg/day as multiple doses during a 4-, 7- or 14-day period.
